LARIMAR THERAPEUTICS, INC. (LRMR) Operating cash flow 2016–2025
LARIMAR THERAPEUTICS, INC. (LRMR) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$113.2MFY2025 · since FY2016: -$52.0M → -$113.2M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$113.2M | -60.0% |
| FY2024 | -$70.8M | -111.5% |
| FY2023 | -$33.5M | -21.4% |
| FY2022 | -$27.6M | +34.5% |
| FY2021 | -$42.1M | +0.2% |
| FY2020 | -$42.2M | -85.9% |
| FY2019 | -$22.7M | +55.9% |
| FY2018 | -$51.5M | -17.6% |
| FY2017 | -$43.8M | +15.8% |
| FY2016 | -$52.0M | — |
Source: SEC XBRL filings · For reference only · Not investment advice